Oesophageal Cancer
Oncology·MeSH: Pancreatic Neoplasms
Prevalence
13.9 / 100K
Incidence
8.0 / 100K/yr
3 drugs in development·3 companies·3 clinical trials
Drug Pipeline by Phase
Phase 3(2)
Phase 1(1)
| Drug | Company |
|---|---|
| CTX-10726 | Compass Therapeutics, Inc. (CMPX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Oesophageal Cancer?
BioSniper tracks 3 drugs in development for Oesophageal Cancer across 3 companies.
How many clinical trials target Oesophageal Cancer?
There are 3 clinical trials targeting Oesophageal Cancer tracked by BioSniper.
What is the prevalence of Oesophageal Cancer?
The estimated prevalence of Oesophageal Cancer is approximately 13.9 per 100,000 population.
Deep-dive into Oesophageal Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis